41 related articles for article (PubMed ID: 35585131)
1. GTSE1 promotes tumor growth and metastasis by attenuating of KLF4 expression in clear cell renal cell carcinoma.
Chen W; Wang H; Lu Y; Huang Y; Xuan Y; Li X; Guo T; Wang C; Lai D; Wu S; Zhao W; Mai H; Li H; Wang B; Ma X; Zhang X
Lab Invest; 2022 Sep; 102(9):1011-1022. PubMed ID: 35585131
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition.
Zhao R; Liang Z; Chu J; Zheng Q; Zhao J; Tang S; Chen Q; Huang Y; Zhou X; Pan X
Pathol Res Pract; 2024 Feb; 254():155068. PubMed ID: 38215565
[TBL] [Abstract][Full Text] [Related]
3. PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway.
Wang L; Yue Y; Zhang L; Jing M; Ma M; Liu C; Li Y; Xu S; Wang K; Wang X; Fan J; Zhang M
Cell Oncol (Dordr); 2023 Oct; 46(5):1317-1332. PubMed ID: 37126128
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract][Full Text] [Related]
5. GTSE1 promotes nasopharyngeal carcinoma proliferation and angiogenesis by upregulating STMN1.
Dong J; Chen J; Wu Y; Yan J
Cell Div; 2024 May; 19(1):16. PubMed ID: 38698443
[TBL] [Abstract][Full Text] [Related]
6. GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway.
Lai W; Zhu W; Li X; Han Y; Wang Y; Leng Q; Li M; Wen X
Lab Invest; 2021 May; 101(5):554-563. PubMed ID: 33328578
[TBL] [Abstract][Full Text] [Related]
7. Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
Zeng B; Wan R; Chang K; Li J; Zhang X; Shi G; Ye D; Xu F
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426605
[TBL] [Abstract][Full Text] [Related]
8. BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS/MAPK pathway via interacting with RPS3A.
Li Z; Zhang M; Chen S; Dong W; Zong R; Wang Y; Fan S
Cell Signal; 2023 Dec; 112():110914. PubMed ID: 37806541
[TBL] [Abstract][Full Text] [Related]
9. SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis.
Wang J; Yin X; He W; Xue W; Zhang J; Huang Y
Acta Pharm Sin B; 2021 Feb; 11(2):406-419. PubMed ID: 33643820
[TBL] [Abstract][Full Text] [Related]
10. Novel cancer-fighting role of ticagrelor inhibits GTSE1-induced EMT by regulating PI3K/Akt/NF-κB signaling pathway in malignant glioma.
Lu E; Zhao B; Yuan C; Liang Y; Wang X; Yang G
Heliyon; 2024 May; 10(9):e30833. PubMed ID: 38774096
[TBL] [Abstract][Full Text] [Related]
11. IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma.
Liu Y; Xing Z; Yuan M; Xu B; Chen L; Zhang D; Zhou Y; Huang H; Zheng X; Zhang J; Jiang J
Pathol Res Pract; 2022 Oct; 238():154069. PubMed ID: 36029680
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis.
Le LN; Choi C; Han JA; Kim EB; Trinh VN; Kim YJ; Ryu S
Front Oncol; 2024; 14():1371934. PubMed ID: 38680858
[TBL] [Abstract][Full Text] [Related]
13. RNF43 is a Novel Tumor Suppressor and Prognostic Indicator in Clear Cell Renal Cell Carcinoma.
Zhu D; Zhang L; Shi X; Gao S; Yue C; Zhang L; Bai Y; Wang Q; Okada A; Yasui T; Wang C; Cui X; Zuo L
Oncol Res; 2021 Jul; ():. PubMed ID: 34215350
[TBL] [Abstract][Full Text] [Related]
14. C-type lectin 2D (CLEC2D) is upregulated in clear cell renal cell carcinoma (ccRCC) tissues and predicts poor prognosis.
Li H; Zheng P; Li Z; Han Q; Zhou B; Wang K
Heliyon; 2024 Mar; 10(6):e27354. PubMed ID: 38509909
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells.
Penna I; Gigoni A; Costa D; Vella S; Russo D; Poggi A; Villa F; Brizzolara A; Canale C; Mescola A; Daga A; Russo C; Nizzari M; Florio T; Menichini P; Pagano A
Oncotarget; 2017 Jan; 8(5):8189-8205. PubMed ID: 28029658
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression.
Ren J; Huang B; Li W; Wang Y; Pan X; Ma Q; Liu Y; Wang X; Liang C; Zhang Y; Wang S; Yang F; Li H; Ning H; Jiang Y; Qin C; Ran A; Xiao B
Transl Oncol; 2024 Apr; 42():101904. PubMed ID: 38341962
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of RNA binding protein 47 predicts low survival in patients and promotes the development of renal cell malignancies through RNA stability modification.
Wang C; Li W; Meng X; Yuan H; Yu T; Yang W; Ni D; Liu L; Xiao W
Mol Biomed; 2023 Nov; 4(1):41. PubMed ID: 37962768
[TBL] [Abstract][Full Text] [Related]
18. PABPN1 promotes clear cell renal cell carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1.
Xiong M; Liu C; Li W; Jiang H; Long W; Zhou M; Yang C; Kazobinka G; Sun Y; Zhao J; Hou T
Carcinogenesis; 2023 Oct; 44(7):576-586. PubMed ID: 37452741
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase STUB1 suppresses tumorigenesis of renal cell carcinomas through regulating YTHDF1 stability.
Ma S; Sun Y; Gao G; Zeng J; Chen K; Zhao Z
Carcinogenesis; 2024 May; ():. PubMed ID: 38795009
[TBL] [Abstract][Full Text] [Related]
20. CD15 is a risk predictor and a novel target in clear cell renal cell carcinoma.
Stenzel PJ; Schindeldecker M; Seidmann L; Herpel E; Hohenfellner M; Hatiboglu G; Foersch S; Porubsky S; Macher-Goeppinger S; Roth W; Tagscherer KE
Pathobiology; 2023 Nov; ():. PubMed ID: 37963432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
